Funds and ETFs Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-05-31 am EDT 5-day change 1st Jan Change
5,578 JPY +3.32% Intraday chart for Daiichi Sankyo Co., Ltd. +2.46% +44.06%

ETFs positioned on Daiichi Sankyo Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
25.16% 19 M€ +11.22%
4.18% 240 M€ +17.47%
3.32% 174 M€ -.--% -
3.32% 51 M€ -.--% -
3.24% 14 M€ +18.47%
2.78% 79 M€ +18.46%
2.69% 60 M€ +24.21%
2.19% 14 M€ +19.96%
2.13% 70 M€ +18.13%
1.96% 9,760 M€ +18.72%
1.95% 4,929 M€ +18.61%
1.78% 0 M€ -.--% -
1.71% 25 M€ +16.23%
1.68% 15,324 M€ +15.05% -
1.64% 28,258 M€ +15.99% -
1.42% 63,295 M€ +18.52% -
1.42% 140,441 M€ +19.22%
1.42% 20,360 M€ +16.70% -
1.35% 17 M€ +14.54% -
1.29% 4 M€ +19.76%
1.08% 57 M€ +19.30%
0.99% 64,792 M€ +15.98%
0.69% 4 M€ -.--% -
0.68% 727 M€ +7.40%
0.44% 25 M€ +3.23% -
0.30% 10 M€ -3.35% -
0.30% 36 M€ +2.36% -
0.25% 7 M€ +5.36% -
0.23% 276 M€ +11.40% -
Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows: - sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis; - other (0.2%): primarily real estate activities. Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,578 JPY
Average target price
5,977 JPY
Spread / Average Target
+7.15%
Consensus
  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. Funds and ETFs Daiichi Sankyo Co., Ltd.